Compile Data Set for Download or QSAR
Report error Found 1614 of ic50 data for polymerid = 3579,7141
TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 50393099BDBM50393099(CHEMBL2152914 | US10231967, Example 122 | US991898...)
Affinity DataIC50: 0.100nMAssay Description:SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at −140° C. at a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 41537BDBM41537(US8865911, 114 | US10231967, Example 114 | US99189...)
Affinity DataIC50: 0.140nMAssay Description:SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at −140° C. at a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 369585BDBM369585(US10231967, Example 94-Isomer-1)
Affinity DataIC50: 0.170nMAssay Description:SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at −140° C. at a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 50393100BDBM50393100(CHEMBL2152915 | US10231967, Example 125 | US991898...)
Affinity DataIC50: 0.260nMAssay Description:SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at −140° C. at a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 136856BDBM136856(US8865911, 92 Isomer 2 | US10231967, Example 92-Is...)
Affinity DataIC50: 0.270nMAssay Description:SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at −140° C. at a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 50393099BDBM50393099(CHEMBL2152914 | US10231967, Example 122 | US991898...)
Affinity DataIC50: 0.280nMAssay Description:SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at −140° C. at a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 50220297BDBM50220297(1-((2R,6S)-1-(4-chlorophenylsulfonyl)-6-(3,5-diflu...)
Affinity DataIC50: 0.300nMAssay Description:Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 levelMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 50393099BDBM50393099(CHEMBL2152914 | US10231967, Example 122 | US991898...)
Affinity DataIC50: 0.300nMAssay Description:SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at −140° C. at a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 50393102BDBM50393102(US8865911, 20t | US8865911, 20t Isomer 1 | US88659...)
Affinity DataIC50: 0.360nMAssay Description:SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at −140° C. at a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 369555BDBM369555(US10231967, Example 68-Isomer-1)
Affinity DataIC50: 0.380nMAssay Description:SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at −140° C. at a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 50393100BDBM50393100(CHEMBL2152915 | US10231967, Example 125 | US991898...)
Affinity DataIC50: 0.5nMAssay Description:SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at −140° C. at a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 136858BDBM136858(US8865911, 94 Isomer 2 | US8865911, 94 Isomer 1 | ...)
Affinity DataIC50: 0.560nMAssay Description:SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at −140° C. at a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 50393102BDBM50393102(US8865911, 20t | US8865911, 20t Isomer 1 | US88659...)
Affinity DataIC50: 0.560nMAssay Description:SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at −140° C. at a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 136739BDBM136739(US8865911, 20e | US10231967, Example 119 | US99189...)
Affinity DataIC50: 0.570nMAssay Description:SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at −140° C. at a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 136863BDBM136863(US8865911, 100 | US10231967, Example 100 | US99189...)
Affinity DataIC50: 0.590nMAssay Description:SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at −140° C. at a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 136761BDBM136761(US8865911, 20u | US9000182, 10 | US10231967, Examp...)
Affinity DataIC50: 0.600nMT: 2°CAssay Description:SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concent...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/19/2015
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 136854BDBM136854(US8865911, 91 | US10231967, Example 91 | US9918985...)
Affinity DataIC50: 0.620nMAssay Description:SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at −140° C. at a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 50393100BDBM50393100(CHEMBL2152915 | US10231967, Example 125 | US991898...)
Affinity DataIC50: 0.630nMAssay Description:The β-secretase enzyme used in the TR-FRET is prepared as follows: The cDNA for the soluble part of the human β-Secretase (AA 1-AA 460) was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 136761BDBM136761(US8865911, 20u | US9000182, 10 | US10231967, Examp...)
Affinity DataIC50: 0.630nMAssay Description:SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at −140° C. at a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 136739BDBM136739(US8865911, 20e | US10231967, Example 119 | US99189...)
Affinity DataIC50: 0.670nMAssay Description:SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at −140° C. at a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 155101BDBM155101(US9000182, 11, isomer 1)
Affinity DataIC50: 0.700nMT: 2°CAssay Description:SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concent...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/19/2015
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 369585BDBM369585(US10231967, Example 94-Isomer-1)
Affinity DataIC50: 0.700nMAssay Description:The β-secretase enzyme used in the TR-FRET is prepared as follows: The cDNA for the soluble part of the human β-Secretase (AA 1-AA 460) was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 369525BDBM369525(US10231967, Example 48-Isomer-1 | US9918985, Examp...)
Affinity DataIC50: 0.700nMAssay Description:The β-secretase enzyme used in the TR-FRET is prepared as follows: The cDNA for the soluble part of the human β-Secretase (AA 1-AA 460) was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 155100BDBM155100(US9000182, 9, isomer 1)
Affinity DataIC50: 0.700nMT: 2°CAssay Description:SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concent...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/19/2015
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 50393100BDBM50393100(CHEMBL2152915 | US10231967, Example 125 | US991898...)
Affinity DataIC50: 0.720nMAssay Description:SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at −140° C. at a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 136863BDBM136863(US8865911, 100 | US10231967, Example 100 | US99189...)
Affinity DataIC50: 0.720nMAssay Description:The β-secretase enzyme used in the TR-FRET is prepared as follows: The cDNA for the soluble part of the human β-Secretase (AA 1-AA 460) was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 50393104BDBM50393104(CHEMBL2152918 | US10231967, Example 20aa | US99189...)
Affinity DataIC50: 0.720nMAssay Description:SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at −140° C. at a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 50393106BDBM50393106(CHEMBL2152920 | US10231967, Example 72 | US9918985...)
Affinity DataIC50: 0.760nMAssay Description:SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at −140° C. at a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 136736BDBM136736(US8865911, 20b | US10231967, Example 20b | US99189...)
Affinity DataIC50: 0.780nMAssay Description:SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at −140° C. at a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 136848BDBM136848(US8865911, 85 | US10231967, Example 85 | US9918985...)
Affinity DataIC50: 0.800nMAssay Description:SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at −140° C. at a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 155120BDBM155120(US9000183, 6 Isomer 1)
Affinity DataIC50: 0.800nMT: 2°CAssay Description:SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concent...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/19/2015
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 155152BDBM155152(US9000185, 8)
Affinity DataIC50: 0.800nMT: 2°CAssay Description:SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concent...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/19/2015
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 136830BDBM136830(US8865911, 68 Isomer 1 | US8865911, 67 | US1023196...)
Affinity DataIC50: 0.810nMAssay Description:SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at −140° C. at a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 136861BDBM136861(US8865911, 98 | US10231967, Example 98 | US9918985...)
Affinity DataIC50: 0.820nMAssay Description:SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at −140° C. at a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 136856BDBM136856(US8865911, 92 Isomer 2 | US10231967, Example 92-Is...)
Affinity DataIC50: 0.840nMAssay Description:The β-secretase enzyme used in the TR-FRET is prepared as follows: The cDNA for the soluble part of the human β-Secretase (AA 1-AA 460) was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 136913BDBM136913(US8865911, 135 | US10231967, Example 135 | US99189...)
Affinity DataIC50: 0.850nMAssay Description:SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at −140° C. at a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 155147BDBM155147(US9000185, 4, isomer 1)
Affinity DataIC50: 0.900nMT: 2°CAssay Description:SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concent...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/19/2015
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 136850BDBM136850(US8865911, 87 | US10231967, Example 87 | US9918985...)
Affinity DataIC50: 0.930nMAssay Description:SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at −140° C. at a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 136739BDBM136739(US8865911, 20e | US10231967, Example 119 | US99189...)
Affinity DataIC50: 0.970nMAssay Description:SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at −140° C. at a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 136847BDBM136847(US8865911, 84 | US10231967, Example 84 | US9918985...)
Affinity DataIC50: 0.990nMAssay Description:SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at −140° C. at a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 103948BDBM103948(US8569521, 144)
Affinity DataIC50: 1nMAssay Description:Gamma-secretase activity was determined as described by Zhang et al. (Biochemistry, 40(16), 5049-5055, 2001).More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2014
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 136833BDBM136833(US8865911, 73 | US9000182, 21, isomer 1 | US102319...)
Affinity DataIC50: 1nMT: 2°CAssay Description:SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concent...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/19/2015
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 50583320BDBM50583320(CHEMBL5084378)
Affinity DataIC50: 1nMAssay Description:Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandw...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 50583322BDBM50583322(CHEMBL5093303)
Affinity DataIC50: 1nMAssay Description:Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandw...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 136833BDBM136833(US8865911, 73 | US9000182, 21, isomer 1 | US102319...)
Affinity DataIC50: 1nMAssay Description:SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at −140° C. at a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 155133BDBM155133(US9000184, 6, isomer 1)
Affinity DataIC50: 1nMT: 2°CAssay Description:SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concent...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/19/2015
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 369599BDBM369599(US10231967, Example 106 | 3-[(1r,4r)-4″-Amin...)
Affinity DataIC50: 1nMAssay Description:The β-secretase enzyme used in the TR-FRET is prepared as follows: The cDNA for the soluble part of the human β-Secretase (AA 1-AA 460) was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 136739BDBM136739(US8865911, 20e | US10231967, Example 119 | US99189...)
Affinity DataIC50: 1.10nMAssay Description:The β-secretase enzyme used in the TR-FRET is prepared as follows: The cDNA for the soluble part of the human β-Secretase (AA 1-AA 460) was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 136849BDBM136849(US8865911, 86 | US10231967, Example 86 | US9918985...)
Affinity DataIC50: 1.10nMAssay Description:SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at −140° C. at a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetAmyloid-beta precursor protein(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 369599BDBM369599(US10231967, Example 106 | 3-[(1r,4r)-4″-Amin...)
Affinity DataIC50: 1.10nMAssay Description:SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at −140° C. at a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

Displayed 1 to 50 (of 1614 total ) | Next | Last >>
Jump to: